🇺🇸 FDA
Patent

US 7795208

Methods of using deacetylase inhibitors to promote cell differentiation and regeneration

granted A61KA61K31/00A61K31/165

Quick answer

US patent 7795208 (Methods of using deacetylase inhibitors to promote cell differentiation and regeneration) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
45
CPC classes
A61K, A61K31/00, A61K31/165, A61K31/19, A61P